Compensation 990
OrganizationsEmployeesBoard MembersGrantsContractorsTop RankingsPricing

Stay updated on 990 organization compensation

© Civic Register LLC

Compensation 990 is an independent service that uses public IRS Form 990 filings as its source data. We clean and standardize this information, but the original filings may contain errors or omissions. Years on this site refer to the organization’s fiscal year end date on the filing.

About•Report a discrepancy•Your privacy choices
Organizations Diseases, Disorders & Medical Congenital Hyperinsulinism International

Congenital Hyperinsulinism International

Fiscal year ending 2024. Filed on September 25, 2025.

PO Box 135
Glen Ridge, New Jersey 07028

Congenital Hyperinsulinism International (EIN: 20-3068945) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Congenital Hyperinsulinism International, a 501(c)(3) charitable organization, reported compensation for 3 out of 9 total employees. Among the employees shown here, the average compensation is $99,690. The highest compensated employee at Congenital Hyperinsulinism International is Julie Raskin with fiscal year 2024 compensation of $114,071.

Revenue, expenses, and employee compensation

Revenue

$1,275,774

Expenses

$1,126,855

Employee compensation

$581,741
Revenue, expenses, and employee compensation over time

Reported Compensated Employees

Julie Raskin
Chief Executive Officer
$114,071
$114,071 No related compNo other comp
Tai Pasquini
CRO
$95,000
$95,000 No related compNo other comp
Jennifer Schmitt
Chief Operating Officer
$90,000
$90,000 No related compNo other comp

Benchmark Employee Compensation

Non-Employee Board Members

Julie Sheldon
Vice President
Justyna Montemurro
Director
Laura Sullivan
President
Mason Smith
Treasurer
Pam Williams
Director
Sheila Bose
Secretary
Trudy Ward
Director

Mission Statement

Congenital Hyperinsulinism International (CHI) is a nonprofit 501(c)(3) corporation dedicated to improving the lives of babies, children, and adults affected by congenital hyperinsulinism (HI). HI is a life-threatening genetic disorder that causes severe low blood sugar (hypoglycemia) in infants and children, though in 50% of patients, the genetic cause is unknown. For those with HI, the beta cells of the pancreas secrete too much insulin in an unregulated manner. Excess insulin causes hypoglycemia. Prolonged or severe hypoglycemia can cause seizures, permanent brain damage, or even death if left untreated. A good prognosis is far more likely with a timely diagnosis and proper management.

Revisions to this organization profile

September 25, 2025:
2024 Congenital Hyperinsulinism International 990 filed
October 12, 2024:
2023 Congenital Hyperinsulinism International 990 filed
November 10, 2023:
2022 Congenital Hyperinsulinism International 990 filed

Get an email when new compensation information is released for Congenital Hyperinsulinism International

Be the first to know when new IRS Form 990 data is published for this organization.

Related Jobs

View more jobs
Powered by Talroo
Report a discrepancy →